Single-cell RNA-Seq and bulk RNA-Seq reveal reliable diagnostic and prognostic biomarkers for CRC

[1]  Wei Zhang,et al.  A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer , 2023, Frontiers in Genetics.

[2]  Yuejun Fang,et al.  Identification of Biomarkers Associated with the Prognoses of Colorectal Cancer Patients , 2022, Digestion.

[3]  Z. Ma,et al.  Development and validation of a prognostic 9-gene signature for colorectal cancer , 2022, Frontiers in Oncology.

[4]  Camille Stephan-Otto Attolini,et al.  Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells , 2022, Nature.

[5]  E. Bernstein,et al.  A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma , 2022, Nature Communications.

[6]  Yan Huang,et al.  Prognostic Assessment of Oxidative Stress-Related Genes in Colorectal Cancer and New Insights into Tumor Immunity , 2022, Oxidative medicine and cellular longevity.

[7]  Ming Zhang,et al.  Molecular Subtypes Based on Cuproptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Colorectal Cancer , 2022, Journal of oncology.

[8]  Chaohan Xu,et al.  Identification of Prognostic Gene Signatures by Developing a scRNA-Seq-Based Integration Approach to Predict Recurrence and Chemotherapy Benefit in Stage II–III Colorectal Cancer , 2022, International journal of molecular sciences.

[9]  Yan Li,et al.  Oncogenic Role of HMGB1 as An Alarming in Robust Prediction of Immunotherapy Response in Colorectal Cancer , 2022, Cancers.

[10]  W. Zheng,et al.  Tumor-Associated Neutrophils in Colorectal Cancer Development, Progression and Immunotherapy , 2022, Cancers.

[11]  Kaixin Huang,et al.  Single-cell and WGCNA uncover a prognostic model and potential oncogenes in colorectal cancer , 2022, Biological Procedures Online.

[12]  P. Coffer,et al.  Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting , 2022, Frontiers in Immunology.

[13]  Jiao Feng,et al.  Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer , 2022, Frontiers in Immunology.

[14]  F. Zou,et al.  BCAP31 is involved in modulating colorectal cancer cell proliferation via the Emerin/β-catenin axis. , 2022, Experimental cell research.

[15]  Yichao Wang,et al.  Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer , 2022, Journal of Translational Medicine.

[16]  K. Jakubowska,et al.  Neutrophil infiltration combined with necrosis in the primary tumor is a useful prognostic indicator for three-year disease-free survival time in patients with colorectal cancer , 2022, Oncology letters.

[17]  C. Sautès-Fridman,et al.  B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome , 2022, Nature Reviews Clinical Oncology.

[18]  Yu Zhang,et al.  SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA , 2022, Frontiers in Cell and Developmental Biology.

[19]  Hubing Shi,et al.  Single-cell transcriptomic profiling unravels the adenoma-initiation role of protein tyrosine kinases during colorectal tumorigenesis , 2022, Signal Transduction and Targeted Therapy.

[20]  Paige N. Vega,et al.  Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps , 2021, Cell.

[21]  I. Luca,et al.  Promising Epigenetic Biomarkers for the Early Detection of Colorectal Cancer: A Systematic Review , 2021, Cancers.

[22]  R. Bernards,et al.  Precision oncology in metastatic colorectal cancer — from biology to medicine , 2021, Nature Reviews Clinical Oncology.

[23]  A. Kundaje,et al.  Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer , 2021, Nature Genetics.

[24]  M. Zheng,et al.  Identification of hub genes associated with neutrophils infiltration in colorectal cancer , 2021, Journal of cellular and molecular medicine.

[25]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[26]  Fachao Zhi,et al.  HMGB1 released from GSDME-mediated pyroptotic epithelial cells participates in the tumorigenesis of colitis-associated colorectal cancer through the ERK1/2 pathway , 2020, Journal of Hematology & Oncology.

[27]  G. Sammarco,et al.  Mast Cells, microRNAs and Others: The Role of Translational Research on Colorectal Cancer in the Forthcoming Era of Precision Medicine , 2020, Journal of clinical medicine.

[28]  P. Schrotz-King,et al.  Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review , 2020, Clinical Epigenetics.

[29]  D. Chung,et al.  Pathways of Colorectal Carcinogenesis. , 2020, Gastroenterology.

[30]  Z. A. Ibrahim,et al.  HMGB1: an overview of its versatile roles in the pathogenesis of colorectal cancer , 2019, Cellular Oncology.

[31]  F. Qiu,et al.  LYRM2 directly regulates complex I activity to support tumor growth in colorectal cancer by oxidative phosphorylation. , 2019, Cancer letters.

[32]  Jau-Song Yu,et al.  Dynamic bioenergetic alterations in colorectal adenomatous polyps and adenocarcinomas , 2019, EBioMedicine.

[33]  Xueda Hu,et al.  Lineage tracking reveals dynamic relationships of T cells in colorectal cancer , 2018, Nature.

[34]  Cheng-Fu Xu,et al.  Olfactomedin-4 in digestive diseases: A mini-review , 2018, World journal of gastroenterology.

[35]  Guohong Liu,et al.  DNA methylation profiles in cancer diagnosis and therapeutics , 2018, Clinical and Experimental Medicine.

[36]  M. Rantalainen.  Application of single-cell sequencing in human cancer , 2017, Briefings in functional genomics.

[37]  R. Longuespée,et al.  OLFM4, KNG1 and Sec24C identified by proteomics and immunohistochemistry as potential markers of early colorectal cancer stages , 2017, Clinical Proteomics.

[38]  J. Guinney,et al.  Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer , 2017, Nature Reviews Cancer.

[39]  S. Sakaguchi,et al.  Regulatory T cells in cancer immunotherapy , 2016, Cell Research.

[40]  I. Maclennan,et al.  Follicular Helper T Cells. , 2016, Annual review of immunology.

[41]  Ye Xu,et al.  FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer , 2015, Immunologic Research.

[42]  K. Tepp,et al.  An in situ study of bioenergetic properties of human colorectal cancer: the regulation of mitochondrial respiration and distribution of flux control among the components of ATP synthasome. , 2014, The international journal of biochemistry & cell biology.

[43]  John M. Asara,et al.  Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function , 2014, Nature.

[44]  G. Sammarco,et al.  Correlation between Serum Tryptase, Mast Cells Positive to Tryptase and Microvascular Density in Colo-Rectal Cancer Patients: Possible Biological-Clinical Significance , 2014, PloS one.

[45]  Z. Trajanoski,et al.  Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. , 2013, Immunity.

[46]  Herbert J Zeh,et al.  Journal of Translational Medicine BioMed Central Review , 2009 .

[47]  O. Warburg,et al.  THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.